The COVID-19 has been a worldwide pandemic and it wants for research associated to impact on individuals’s demand for insurance throughout the pandemic which is a vital solution to switch threat. However, there’s a lack of analysis linking COVID-19 and other people’s demand for insurance. The goal of this paper is to analyze the impact of COVID-19 pandemic on issuance demand, utilizing knowledge overlaying 241 cities on confirmed COVID-19 circumstances and insurance firm income in China.
The empirical outcomes present that extra confirmed COVID-19 circumstances are related to better per capita insurance income and the outcomes are strong when contemplating endogeneity concern.
Economically, the per capita insurance income will increase by 0.896 Yuan for every extra confirmed case. In phrases of insurance kind, the best elevated insurance income is for all times insurance, adopted by well being insurance. We additional think about the heterogeneity of areas and discover that the impact of COVID-19 on insurance income solely exists in areas with worse medical therapy circumstances or larger medical burden.
Acquired ABC-transporter overexpression in most cancers cells: transcriptional induction or Darwinian choice?
Acquired multidrug resistance (MDR) in tumor illnesses has repeatedly been related to overexpression of ATP-binding cassette transporters (ABC-transporters) corresponding to P-glycoprotein. Both in vitro and in vivo knowledge counsel that these efflux transporters may cause MDR, albeit its precise relevance for medical chemotherapy unresponsiveness stays unsure. The overexpression can experimentally be achieved by publicity of tumor cells to cytotoxic medicine.
For simplification, the drug-mediated transporter overexpression will be attributed to 2 reverse mechanisms: First, elevated transcription of ABC-transporter genes mediated by nuclear receptors sensing the respective compound. Second, Darwinian choice of sub-clones intrinsically overexpressing drug transporters being succesful of extruding the respective drug. To date, there isn’t a particular knowledge indicating which mechanism actually applies or whether or not there are circumstances selling both mode of motion.
This evaluation summarizes experimental proof for each theories, suggests an algorithm discriminating between these two modes, and at last factors out future experimental approaches of analysis to reply this primary query in most cancers pharmacology.
Facilitating Growth Mixture Model Convergence in Preventive Interventions
Growth combination fashions (GMMs) are utilized to intervention research with repeated measures to discover heterogeneity in the intervention impact. However, conventional GMMs are recognized to be troublesome to estimate, particularly at pattern sizes frequent in single-center interventions. Common methods to coerce GMMs to converge contain put up hoc changes to the mannequin, notably constraining covariance parameters to equality throughout courses.
Methodological research have proven that though convergence is improved with put up hoc changes, they embed extra tenuous assumptions into the mannequin that may adversely impact key points of the mannequin corresponding to quantity of courses extracted and the estimated progress trajectories in every class. To facilitate convergence with out put up hoc changes, this paper critiques the current literature on covariance sample combination fashions, which method GMMs from a marginal modeling custom fairly than the random impact modeling custom utilized by conventional GMMs.
We talk about how the marginal modeling custom can keep away from complexities in estimation encountered by GMMs that function random results, and we use knowledge from a life-style intervention for rising insulin sensitivity (a threat issue for kind 2 diabetes) amongst 90 Latino adolescents with weight problems to reveal our level. Specifically, GMMs that includes random effects-even with put up hoc adjustments-fail to converge as a result of estimation errors, whereas covariance sample combination fashions following the marginal mannequin custom encounter no points with estimation whereas sustaining the capability to reply all the analysis questions.

Effect of storage time on the urine protein: creatinine ratio in alkaline ovine urine
The urine protein:creatinine (UPC) ratio is taken into account the reference methodology to evaluate proteinuria. Its diagnostic worth in ovine drugs wants additional elucidation. In inhabitants monitoring and/or for analysis functions, it’s handy to gather many samples concurrently and retailer them for later evaluation. However, analyte stability knowledge are required to make sure dependable outcomes. We used 15 of 90 urine samples collected from sheep to evaluate the impact of storage time on the UPC ratio. After centrifugation, the supernatant of every pattern was divided into 6 aliquots.
Urine protein and creatinine concentrations had been decided instantly in a single aliquot utilizing the pyrogallol purple and a modified Jaffè methodology, respectively. The different aliquots had been saved at -18°C. Based on the absence of energetic sediment, alkaline urine pH, and UPC ratio ≥ 0.2, we included 15 samples in our research.
The UPC ratio was decided in the saved aliquots 2, 7, 14, 21, and 60 d after assortment. The knowledge had been analyzed with univariate ANOVA. No important distinction was noticed in the urinary concentrations of protein, creatinine, and the UPC ratio (0.8 ± 0.84 in typical models and 0.09 ± 0.095 in SI models) amongst totally different instances (p > 0.05). The UPC ratio remained steady for two mo in ovine urine samples saved at -18°C.
Multimodal Disentangled Variational Autoencoder with Game Theoretic Interpretability for Glioma grading
Effective fusion of multimodal magnetic resonance imaging (MRI) is of nice significance to spice up the accuracy of glioma grading because of the complementary info supplied by totally different imaging modalities. However, how you can extract the frequent and distinctive info from MRI to realize complementarity remains to be an open downside in info fusion analysis. In this research, we suggest a deep neural community mannequin termed as multimodal disentangled variational autoencoder (MMD-VAE) for glioma grading based mostly on radiomics options extracted from preoperative multimodal MRI photographs.
Specifically, the radiomics options are quantized and extracted from the area of curiosity for every modality. Then, the latent representations of variational autoencoder for these options are disentangled into frequent and distinctive representations to acquire the shared and complementary knowledge amongst modalities. Afterward, cross-modality reconstruction loss and common-distinctive loss are designed to make sure the effectiveness of the disentangled representations.
Finally, the disentangled frequent and distinctive representations are fused to foretell the glioma grades, and SHapley Additive exPlanations (SHAP) is adopted to quantitatively interpret and analyze the contribution of the essential options to grading.
FGF21 Polyclonal Antibody |
ABP58547-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of FGF21 from Human. This FGF21 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human FGF21 protein at amino acid sequence of 90-170 |
FGF21 Polyclonal Antibody |
ES9145-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
Description: A Rabbit Polyclonal antibody against FGF21 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
FGF21 Polyclonal Antibody |
ES9145-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
Description: A Rabbit Polyclonal antibody against FGF21 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
FGF21 Polyclonal Antibody |
A52640-020 |
EpiGentek |
20 ul |
Ask for price |
FGF21 Polyclonal Antibody |
A52640-050 |
EpiGentek |
50 ul |
Ask for price |
FGF21 Polyclonal Antibody |
A52640-100 |
EpiGentek |
100 ul |
EUR 423.5 |
FGF21 Polyclonal Antibody |
A70977-050 |
EpiGentek |
50 ul |
EUR 302.5 |
FGF21 Polyclonal Antibody |
A70977-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Fgf21 Polyclonal Antibody |
A62586-020 |
EpiGentek |
20 ul |
EUR 117.7 |
Fgf21 Polyclonal Antibody |
A62586-050 |
EpiGentek |
50 ul |
EUR 302.5 |
Fgf21 Polyclonal Antibody |
A62586-100 |
EpiGentek |
100 ul |
EUR 423.5 |
FGF21 Polyclonal Antibody |
A52640 |
EpiGentek |
-
EUR 684.66
-
Ask for price
-
Ask for price
-
EUR 423.50
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
Fgf21 Polyclonal Antibody |
A62586 |
EpiGentek |
-
EUR 684.66
-
EUR 117.70
-
EUR 302.50
-
EUR 423.50
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
Anti-FGF21 Biotinylated Antibody |
A00802-Biotin |
BosterBio |
50ug/vial |
EUR 352.8 |
FGF21 antibody |
70R-14210 |
Fitzgerald |
100 ug |
EUR 386.4 |
Description: Affinity purified Rabbit polyclonal FGF21 antibody |
FGF21 Antibody |
49516-100ul |
SAB |
100ul |
EUR 399.6 |
FGF21 Antibody |
49516-50ul |
SAB |
50ul |
EUR 286.8 |
FGF21 Antibody |
36478-100ul |
SAB |
100ul |
EUR 302.4 |
FGF21 antibody |
10R-6940 |
Fitzgerald |
100 ul |
EUR 829.2 |
Description: Mouse monoclonal FGF21 antibody |
FGF21 antibody |
10R-6941 |
Fitzgerald |
100 ul |
EUR 829.2 |
Description: Mouse monoclonal FGF21 antibody |
FGF21 antibody |
10R-4103 |
Fitzgerald |
100 ul |
EUR 829.2 |
Description: Mouse monoclonal FGF21 antibody |
FGF21 antibody |
10R-4104 |
Fitzgerald |
100 ul |
EUR 829.2 |
Description: Mouse monoclonal FGF21 antibody |
FGF21 antibody |
10R-4106 |
Fitzgerald |
100 ul |
EUR 829.2 |
Description: Mouse monoclonal FGF21 antibody |
FGF21 antibody |
10R-4108 |
Fitzgerald |
100 ul |
EUR 829.2 |
Description: Mouse monoclonal FGF21 antibody |
FGF21 antibody |
10R-4111 |
Fitzgerald |
100 ul |
EUR 871.2 |
Description: Mouse monoclonal FGF21 antibody |
FGF21 antibody |
10R-4112 |
Fitzgerald |
100 ul |
EUR 829.2 |
Description: Mouse monoclonal FGF21 antibody |
FGF21 antibody |
70R-6198 |
Fitzgerald |
50 ug |
EUR 560.4 |
Description: Rabbit polyclonal FGF21 antibody raised against the N terminal of FGF21 |
FGF21 Antibody |
1-CSB-PA876229 |
Cusabio |
|
|
|
Description: A polyclonal antibody against FGF21. Recognizes FGF21 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
FGF21 Antibody |
1-CSB-PA06404A0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against FGF21. Recognizes FGF21 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200 |
FGF21 Antibody |
1-CSB-PA290047 |
Cusabio |
|
|
|
Description: A polyclonal antibody against FGF21. Recognizes FGF21 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:25-1:100 |
Fgf21 Antibody |
1-CSB-PA008627LA01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Fgf21. Recognizes Fgf21 from Mouse. This antibody is Unconjugated. Tested in the following application: ELISA |
anti-FGF21 |
YF-PA18287 |
Abfrontier |
50 ul |
EUR 435.6 |
Description: Mouse polyclonal to FGF21 |
anti-FGF21 |
YF-PA18288 |
Abfrontier |
50 ug |
EUR 435.6 |
Description: Mouse polyclonal to FGF21 |
anti-FGF21 |
YF-PA18289 |
Abfrontier |
100 ug |
EUR 483.6 |
Description: Rabbit polyclonal to FGF21 |
Anti-FGF21 Rabbit Monoclonal Antibody |
M00802 |
BosterBio |
100ug/vial |
EUR 476.4 |
Description: Anti-FGF21 Rabbit Monoclonal Antibodytested for IHC, WB in Human, Mouse, Rat |
FGF21 Polyclonal Antibody, Biotin Conjugated |
A52637-050 |
EpiGentek |
50 ul |
EUR 302.5 |
FGF21 Polyclonal Antibody, Biotin Conjugated |
A52637-100 |
EpiGentek |
100 ul |
EUR 423.5 |
FGF21 Polyclonal Antibody, FITC Conjugated |
A52638-050 |
EpiGentek |
50 ul |
EUR 302.5 |
FGF21 Polyclonal Antibody, FITC Conjugated |
A52638-100 |
EpiGentek |
100 ul |
EUR 423.5 |
FGF21 Polyclonal Antibody, HRP Conjugated |
A52639-050 |
EpiGentek |
50 ul |
EUR 302.5 |
FGF21 Polyclonal Antibody, HRP Conjugated |
A52639-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Fgf21 Polyclonal Antibody, HRP Conjugated |
A62587-050 |
EpiGentek |
50 ul |
EUR 302.5 |
Fgf21 Polyclonal Antibody, HRP Conjugated |
A62587-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Fgf21 Polyclonal Antibody, FITC Conjugated |
A62588-050 |
EpiGentek |
50 ul |
EUR 302.5 |
Fgf21 Polyclonal Antibody, FITC Conjugated |
A62588-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Fgf21 Polyclonal Antibody, Biotin Conjugated |
A62589-050 |
EpiGentek |
50 ul |
EUR 302.5 |
Fgf21 Polyclonal Antibody, Biotin Conjugated |
A62589-100 |
EpiGentek |
100 ul |
EUR 423.5 |
FGF21 Polyclonal Antibody, Biotin Conjugated |
A52637 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
FGF21 Polyclonal Antibody, FITC Conjugated |
A52638 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
FGF21 Polyclonal Antibody, HRP Conjugated |
A52639 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Fgf21 Polyclonal Antibody, HRP Conjugated |
A62587 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Fgf21 Polyclonal Antibody, FITC Conjugated |
A62588 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Fgf21 Polyclonal Antibody, Biotin Conjugated |
A62589 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Polyclonal Goat anti-GST α-form |
GST-ANTI-1 |
Detroit R&D |
50 uL |
EUR 336 |
Polyclonal Goat anti-GST μ-form |
GST-ANTI-2 |
Detroit R&D |
50 uL |
EUR 336 |
Polyclonal Goat anti-GST p-form |
GST-ANTI-3 |
Detroit R&D |
50 uL |
EUR 336 |
OR Antibody |
44609-100ul |
SAB |
100ul |
EUR 302.4 |
OR Antibody |
44609-50ul |
SAB |
50ul |
EUR 224.4 |
OR Antibody |
20-abx217389 |
Abbexa |
|
|
|
FGF21 antibody (biotin) |
60R-1444 |
Fitzgerald |
100 ug |
EUR 392.4 |
Description: Rabbit polyclonal FGF21 antibody (biotin) |
FGF21 Conjugated Antibody |
C36478 |
SAB |
100ul |
EUR 476.4 |
FGF21 Conjugated Antibody |
C49516 |
SAB |
100ul |
EUR 476.4 |
Human Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
DLR-FGF21-Hu-48T |
DL Develop |
48T |
EUR 426 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Fibroblast Growth Factor 21 (FGF21) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
DLR-FGF21-Hu-96T |
DL Develop |
96T |
EUR 541.2 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Fibroblast Growth Factor 21 (FGF21) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
DLR-FGF21-Mu-48T |
DL Develop |
48T |
EUR 568.8 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Fibroblast Growth Factor 21 (FGF21) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
DLR-FGF21-Mu-96T |
DL Develop |
96T |
EUR 736.8 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Fibroblast Growth Factor 21 (FGF21) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Porcine Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
DLR-FGF21-p-48T |
DL Develop |
48T |
EUR 645.6 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Fibroblast Growth Factor 21 (FGF21) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Porcine Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
DLR-FGF21-p-96T |
DL Develop |
96T |
EUR 843.6 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Fibroblast Growth Factor 21 (FGF21) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rat Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
DLR-FGF21-Ra-48T |
DL Develop |
48T |
EUR 594 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Fibroblast Growth Factor 21 (FGF21) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rat Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
DLR-FGF21-Ra-96T |
DL Develop |
96T |
EUR 772.8 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Fibroblast Growth Factor 21 (FGF21) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
RDR-FGF21-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 423.6 |
Human Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
RDR-FGF21-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 579.6 |
Mouse Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
RDR-FGF21-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 591.6 |
Mouse Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
RDR-FGF21-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 819.6 |
Porcine Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
RDR-FGF21-p-48Tests |
Reddot Biotech |
48 Tests |
EUR 684 |
Porcine Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
RDR-FGF21-p-96Tests |
Reddot Biotech |
96 Tests |
EUR 951.6 |
Rat Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
RDR-FGF21-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 622.8 |
Rat Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
RDR-FGF21-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 864 |
Human Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
RD-FGF21-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 406.8 |
Human Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
RD-FGF21-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 555.6 |
Mouse Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
RD-FGF21-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 566.4 |
Mouse Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
RD-FGF21-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 783.6 |
Porcine Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
RD-FGF21-p-48Tests |
Reddot Biotech |
48 Tests |
EUR 654 |
Porcine Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
RD-FGF21-p-96Tests |
Reddot Biotech |
96 Tests |
EUR 908.4 |
Rat Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
RD-FGF21-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 595.2 |
Rat Fibroblast Growth Factor 21 (FGF21) ELISA Kit |
RD-FGF21-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 825.6 |
Myeloid/lymphoid or mixed-lineage leukemia translocated to 10 (MLLT10) polyclonal antibody |
ABP-PAB-10850 |
Allele Biotech |
100 ug |
Ask for price |
|
Myeloid/lymphoid or mixed-lineage leukemia translocated to 1 (MLLT1) polyclonal antibody |
ABP-PAB-10851 |
Allele Biotech |
100 ug |
Ask for price |
|
Myeloid/lymphoid or mixed-lineage leukemia translocated to 2 (MLLT2) polyclonal antibody |
ABP-PAB-10852 |
Allele Biotech |
100 ug |
Ask for price |
|
Myeloid/lymphoid or mixed-lineage leukemia translocated to 3 (MLLT3) polyclonal antibody |
ABP-PAB-10853 |
Allele Biotech |
100 ug |
Ask for price |
|
Myeloid/lymphoid or mixed-lineage leukemia translocated to 4 (MLLT4) polyclonal antibody |
ABP-PAB-10854 |
Allele Biotech |
100 ug |
Ask for price |
|
Myeloid/lymphoid or mixed-lineage leukemia translocated to 6 (MLLT6) polyclonal antibody |
ABP-PAB-10855 |
Allele Biotech |
100 ug |
Ask for price |
|
Myeloid/lymphoid or mixed-lineage leukemia translocated to 7 (MLLT7) polyclonal antibody |
ABP-PAB-10856 |
Allele Biotech |
100 ug |
Ask for price |
|
Anti-FGF21 (3E20) |
YF-MA20531 |
Abfrontier |
200 ul |
EUR 435.6 |
Description: Mouse monoclonal to FGF21 |
Anti-FGF21 (2F11) |
YF-MA11430 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to FGF21 |
Anti-FGF21 (1A8) |
YF-MA11431 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to FGF21 |
Anti-FGF21 (3G10) |
YF-MA11432 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to FGF21 |
Anti-FGF21 (3A6) |
YF-MA11433 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to FGF21 |
Anti-FGF21 (3E8) |
YF-MA11434 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to FGF21 |
OR Conjugated Antibody |
C44609 |
SAB |
100ul |
EUR 476.4 |
FGF21 recombinant monoclonal antibody |
A5710 |
Bimake |
100ul X 3 |
EUR 714 |
|
Description: A recombinant monoclonal antibody from rabbit against human FGF21 for WB ,ELISA |
FGF21 Antibody, HRP conjugated |
1-CSB-PA06404B0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against FGF21. Recognizes FGF21 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
FGF21 Antibody, FITC conjugated |
1-CSB-PA06404C0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against FGF21. Recognizes FGF21 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
FGF21 Antibody, Biotin conjugated |
1-CSB-PA06404D0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against FGF21. Recognizes FGF21 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Fgf21 Antibody, HRP conjugated |
1-CSB-PA008627LB01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Fgf21. Recognizes Fgf21 from Mouse. This antibody is HRP conjugated. Tested in the following application: ELISA |
Fgf21 Antibody, FITC conjugated |
1-CSB-PA008627LC01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Fgf21. Recognizes Fgf21 from Mouse. This antibody is FITC conjugated. Tested in the following application: ELISA |
Fgf21 Antibody, Biotin conjugated |
1-CSB-PA008627LD01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Fgf21. Recognizes Fgf21 from Mouse. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Polyclonal TRAF3IP2 Antibody (C or N-Term) |
AMM08309G |
Leading Biology |
0.1 mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human TRAF3IP2 (C or N-Term). This antibody is tested and proven to work in the following applications: |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Human) |
4-PAC918Hu01 |
Cloud-Clone |
-
EUR 246.00
-
EUR 2220.00
-
EUR 570.00
-
EUR 300.00
-
EUR 235.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Fibroblast Growth Factor 21 (FGF21) |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Mouse) |
4-PAC918Mu02 |
Cloud-Clone |
-
EUR 301.20
-
EUR 3091.20
-
EUR 768.00
-
EUR 379.20
-
EUR 258.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Fibroblast Growth Factor 21 (FGF21) |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Rat) |
4-PAC918Ra01 |
Cloud-Clone |
-
EUR 310.80
-
EUR 3249.60
-
EUR 804.00
-
EUR 393.60
-
EUR 262.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Rat Fibroblast Growth Factor 21 (FGF21) |
Polyclonal Goat Anti-GOT2 (aa 295 to 306) Antibody |
AMM04997G |
Leading Biology |
0.1 mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-GOT2 (aa 295 to 306) . This antibody is tested and proven to work in the following applications: |
Polyclonal Goat Anti-GOT2 (aa 360 to 373) Antibody |
AMM04998G |
Leading Biology |
0.1 mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-GOT2 (aa 360 to 373) . This antibody is tested and proven to work in the following applications: |
Polyclonal Goat Anti-Renalase (aa 134 to 147) Antibody |
AMM05956G |
Leading Biology |
0.1 mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-Renalase (aa 134 to 147) . This antibody is tested and proven to work in the following applications: |
Polyclonal Goat Anti-Renalase (aa 224 to 233) Antibody |
APG03367G |
Leading Biology |
0.1 mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-Renalase (aa 224 to 233) . This antibody is tested and proven to work in the following applications: |
DNA-(apurinic or apyrimidinic site) lyase Polyclonal Antibody |
42068-100ul |
SAB |
100ul |
EUR 399.6 |
ATF2 (Phospho-Ser62 or 44) Polyclonal Conjugated Antibody |
C11029 |
SAB |
100ul |
EUR 476.4 |
ATF2 (Phospho-Thr69 or 51) Polyclonal Conjugated Antibody |
C11030 |
SAB |
100ul |
EUR 476.4 |
ATF2 (Phospho-Thr71 or 53) Polyclonal Conjugated Antibody |
C11031 |
SAB |
100ul |
EUR 476.4 |
ATF2 (Phospho-Thr73 or 55) Polyclonal Conjugated Antibody |
C11032 |
SAB |
100ul |
EUR 476.4 |
ATF2 (Phospho-Ser112 or 94) Polyclonal Conjugated Antibody |
C11033 |
SAB |
100ul |
EUR 476.4 |
Polyclonal Trp63 (mouse) Antibody (C or N-Term) |
APG00814G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Trp63 (mouse) (C or N-Term). This antibody is tested and proven to work in the following applications: |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Human), APC |
4-PAC918Hu01-APC |
Cloud-Clone |
-
EUR 338.40
-
EUR 2850.00
-
EUR 824.40
-
EUR 420.00
-
EUR 230.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with APC. |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Human), Biotinylated |
4-PAC918Hu01-Biotin |
Cloud-Clone |
-
EUR 318.00
-
EUR 2160.00
-
EUR 674.40
-
EUR 378.00
-
EUR 238.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with Biotin. |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Human), Cy3 |
4-PAC918Hu01-Cy3 |
Cloud-Clone |
-
EUR 402.00
-
EUR 3750.00
-
EUR 1050.00
-
EUR 510.00
-
EUR 258.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with Cy3. |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Human), FITC |
4-PAC918Hu01-FITC |
Cloud-Clone |
-
EUR 295.20
-
EUR 2304.00
-
EUR 684.00
-
EUR 360.00
-
EUR 208.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with FITC. |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Human), HRP |
4-PAC918Hu01-HRP |
Cloud-Clone |
-
EUR 313.20
-
EUR 2490.00
-
EUR 734.40
-
EUR 384.00
-
EUR 219.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with HRP. |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Human), PE |
4-PAC918Hu01-PE |
Cloud-Clone |
-
EUR 295.20
-
EUR 2304.00
-
EUR 684.00
-
EUR 360.00
-
EUR 208.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with PE. |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Mouse), APC |
4-PAC918Mu02-APC |
Cloud-Clone |
-
EUR 421.20
-
EUR 4038.00
-
EUR 1122.00
-
EUR 538.80
-
EUR 266.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with APC. |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Mouse), Biotinylated |
4-PAC918Mu02-Biotin |
Cloud-Clone |
-
EUR 379.20
-
EUR 3031.20
-
EUR 892.80
-
EUR 464.40
-
EUR 265.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with Biotin. |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Mouse), Cy3 |
4-PAC918Mu02-Cy3 |
Cloud-Clone |
-
EUR 512.40
-
EUR 5334.00
-
EUR 1446.00
-
EUR 668.40
-
EUR 304.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with Cy3. |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Mouse), FITC |
4-PAC918Mu02-FITC |
Cloud-Clone |
-
EUR 361.20
-
EUR 3254.40
-
EUR 921.60
-
EUR 454.80
-
EUR 236.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with FITC. |
Experimental outcomes on two benchmark knowledgeunits reveal that the proposed MMD-VAE mannequin achieves encouraging predictive efficiency (AUC:0.9939) on a public knowledgeset, and good generalization efficiency (AUC:0.9611) on a cross-institutional personal knowledgeset. These quantitative outcomes and interpretations could assist radiologists perceive gliomas higher and make higher therapy selections for bettering medical outcomes.